Due to lower assumptions on ex-US ICD industry market growth, Goldman Sachs has updated its FY2011-2013 EPS estimates on Medtronic MDT to $3.38/$3.63/$3.95 from $3.39/$3.63/$3.96. It does not view these changes as material, and there is no change to the investment thesis, rating or price target.
Goldman Sachs has a $45 PT and Buy rating on MDT
MDT closed Monday at $39.54
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in